Real-time enrollment status for this to assess the feasibility, visualization capability, and optimal dosing of icg fluorescence imaging for intraoperative assessment of knee tissue perfusion clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 10:33 AM UTC
| NCT Number | NCT07793266 |
| Recruiting Status | Recruiting |
| Condition | To Assess the Feasibility, Visualization Capability, and Optimal Dosing of ICG Fluorescence Imaging for Intraoperative Assessment of Knee Tissue Perfusion |
| Phase | PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Henry Ford Health System |
| Last Updated on CT.gov | August 28, 2026 (Aug 28, 2026) |
As of October 15, 2026: Clinical trial NCT07793266 is currently recruiting participants. This phase1 study for to assess the feasibility, visualization capability, and optimal dosing of icg fluorescence imaging for intraoperative assessment of knee tissue perfusion is actively seeking new participants at 1 location across the United States. The study is sponsored by Henry Ford Health System. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07793266 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07793266 was last updated Aug 28, 2026 (August 28, 2026). HelloStudys verifies this status automatically.